MVA85A vaccine to enhance BCG for preventing tuberculosis

BACKGROUND: Tuberculosis causes more deaths than any other infectious disease globally. Bacillus Calmette‐Guérin (BCG) is the only available vaccine, but protection is incomplete and variable. The modified Vaccinia Ankara virus expressing antigen 85A (MVA85A) is a viral vector vaccine produced to pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kashangura, Rufaro, Jullien, Sophie, Garner, Paul, Johnson, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488980/
https://www.ncbi.nlm.nih.gov/pubmed/31038197
http://dx.doi.org/10.1002/14651858.CD012915.pub2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488980/
https://www.ncbi.nlm.nih.gov/pubmed/31038197
http://dx.doi.org/10.1002/14651858.CD012915.pub2

Ejemplares similares